We are live on ! Find out more
TCM

Texan Capital Management Portfolio holdings

AUM $154M
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+2.76%
1 Year Est. Return
+10.82%
3 Year Est. Return
+19.3%
5 Year Est. Return
10 Year Est. Return
AUM
$214M
AUM Growth
+$1.85M
Cap. Flow
-$2.42M
Cap. Flow %
-1.13%
Top 10 Hldgs %
25.62%
Holding
135
New
7
Increased
33
Reduced
52
Closed
5

Sector Composition

Rank Sector Weight
1 Energy 34.44%
2 Healthcare 11.52%
3 Financials 8.75%
4 Communication Services 8.34%
5 Technology 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNR
126
DELISTED
Denbury Resources, Inc.
DNR
$98K 0.05%
26,500
-2,000
-7% -$6.43K
TGA
127
DELISTED
Transglobe Energy Corp
TGA
$51K 0.02%
30,000
+15,000
+100% +$27.7K
CIVI
128
DELISTED
Civitas Resources
CIVI
$19K 0.01%
171
+10
+6% +$1.28K
DELL icon
129
Dell
DELL
$297B
-29,853
Closed -$401K
DFS
130
DELISTED
Discover Financial Services
DFS
-4,310
Closed -$244K
GS icon
131
Goldman Sachs
GS
$301B
-11,561
Closed -$1.86M
UA icon
132
Under Armour Class C
UA
$2.15B
-33,965
Closed -$1.15M
VLO icon
133
Valero Energy
VLO
$101B
-7,807
Closed -$414K
AIG.WS
134
DELISTED
American International Group, Inc.
AIG.WS
$0 ﹤0.01%
96,649

Similar funds

Texan Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Texan Capital Management held 135 positions worth $214M, up 0.87% from $212M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Texan Capital Management's Q4 2016 filing shows 7 new, 33 increased, 52 reduced and 5 closed positions. Its largest new stake was Abiomed Inc: 8,719 shares worth $982K. The largest sale was Bristol-Myers Squibb, an estimated $1.98M.

By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.

  • Texan Capital Management's largest Q4 2016 buy was Abiomed Inc: 8,719 shares worth $982K.
  • Texan Capital Management added most to Procter & Gamble in Q4 2016, an estimated $1.18M increase.
  • Texan Capital Management's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $1.98M.
  • Texan Capital Management fully exited Goldman Sachs in Q4 2016, selling an estimated $1.86M.
  • Texan Capital Management's ten largest holdings make up 26% of its $214M portfolio in Q4 2016.
  • Texan Capital Management opened 7 new positions and closed 5 in Q4 2016.
  • Texan Capital Management's portfolio value rose 0.87% quarter-over-quarter to $214M.

Based on Texan Capital Management's 13F filing for Q4 2016, filed 3 Feb 2017.